You’ve heard of long Covid, a condition in which the acute infection subsides but troubling symptoms persist. Less well known is chronic Covid: The virus just doesn’t leave, sometimes staying in ...
Are we there yet? It’s a common question and one that millions of Americans have been asking since around the end of March 2020. Are we finally done with this awful pandemic? Not yet, say scientists ...
When the CDC was preparing to recommend the new bivalent COVID booster vaccines (speaking of which, most of us should make plans to get one), they also mentioned that more people should be aware of ...
President Biden and his COVID-19 response coordinator Dr. Ashish Jha rightfully have been raising concern that “new variants may make some existing protections ineffective for the immunocompromised” ...
As the U.S. grapples with the lasting effects of the Covid-19 pandemic, it is important to highlight the ongoing challenges faced by the 7 million immunocompromised Americans. For them, the battle ...
The federal government is trying to make it easier for immunocompromised patients to access a treatment that can protect them against COVID-19 by allowing individual health care providers to order ...
A study from Johns Hopkins Medicine reveals that older adults with weakened immune systems, such as organ transplant recipients, may not produce sufficient protective antibodies against respiratory ...
DEAR DR ROACH: Would you please clarify what it means to be immunocompromised? Is it the same as having an immune disorder? If a person has an autoimmune disorder, are they considered ...
Here are the precautions people who are immunocompromised should take before returning to the office
Many pandemic restrictions have been lifted for the vaccinated, but for the millions of people with conditions that suppress the immune system, who may not get as much protection from a Covid-19 ...
Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity - primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback